The strength of BioIncubate lies in the success of its teams

Discover all our teams and find out how they’re shaping the future of biotech!

UNOMR

BioIncubate 2023/24 Startup Track Winner - CHF 25000 grant

Find out more on https://unomr.com/

Single-protein analysis to unlock the power of proteomics.

UNOMR is revolutionizing single-molecule protein analysis with its patented serial nanopore sensor, initially targeting protein glycosylation. Addressing a USD 60 billion market, their technology unlocks new possibilities in healthcare, drug development, and food science. With a vision to bring advanced proteomics to the patient, UNOMR is paving the way for the next leap in precision medicine.

  • In May 2025 UNOMR receives CHF 150,000 from Venture Kick to bring a new dimension to proteomics analysis.

    Read the linkedin post here

  • In March 2024, the BRIDGE Programme announced successful funding of the UNOMR project!

    This program, jointly funded by SNSF and Innosuisse, empowers researchers to swiftly transform their findings into products or services.

  • Aptamer-Functionalized Interface Nanopores Enable Amino Acid-Specific Peptide Detection

    Cofounders Julian Hengsteler & Til Schlotter, in collaboration with Nako Nakatsuka, Ph.D., published an exciting paper demonstrating UNOMR’s ability to target specific amino-acids on peptides with their aptamer-functionalized interface nanopores.

    Read the paper here


ATLYPHE

BioIncubate 2023/24 BioPitch Gala Winner - CHF 5000 grant

ATLyphe are a pre-clinical biotech spin-off from the ETH Zurich and University of Zurich. They are focused in the area of precision medicine, working on a T-cell engager and activator technology, with the goal to make hematopoetic transplant of stem cells safer and more effective.

Read here their interview with BioIncubate!

  • In February 2021, the Phire (former name) project was admitted as a full project at Wyss Zurich, a joint translational center of ETH Zurich and the University of Zurich.

  • From March 2021 to March 2022 they received financial and entrepreneurial support.


  • Coming soon

  • Coming soon

  • Coming soon

Our Partners & Supporters